These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 15332415

  • 21. Conclusions regarding the efficacy of treatments for neuroleptic malignant syndrome should be tempered given poor quality data, regardless of the analysis conducted.
    Roberts DM, Roberts JA.
    Crit Care; 2007; 11(3):413; author reply 413. PubMed ID: 17488492
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Neuroleptic malignant syndrome in a burn patient.
    Still J, Friedman B, Law E, Deppe S, Epperly N, Orlet H.
    Burns; 1998 Sep; 24(6):573-5. PubMed ID: 9776099
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Successful electroconvulsive therapy in a pregnant woman with neuroleptic malignant syndrome].
    Verwiel JM, Verwey B, Heinis C, Thies JE, Bosch FH.
    Ned Tijdschr Geneeskd; 1994 Jan 22; 138(4):196-9. PubMed ID: 8107921
    [Abstract] [Full Text] [Related]

  • 28. Navigating neuroleptic malignant syndrome.
    Cahill C, Arana GW.
    Am J Nurs; 1986 Jun 22; 86(6):670-3. PubMed ID: 3636063
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Catatonia and neuroleptic malignant syndrome: two sides of a coin?
    Vancaester E, Santens P.
    Acta Neurol Belg; 2007 Jun 22; 107(2):47-50. PubMed ID: 17710840
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Neuroleptic malignant syndrome associated with metoclopramide in a burn patient.
    Nachreiner R, Balledux J, Zieger M, Viegas O, Sood R.
    J Burn Care Res; 2006 Jun 22; 27(2):237-41. PubMed ID: 16566575
    [Abstract] [Full Text] [Related]

  • 33. Mortality from neuroleptic malignant syndrome.
    Shalev A, Hermesh H, Munitz H.
    J Clin Psychiatry; 1989 Jan 22; 50(1):18-25. PubMed ID: 2562951
    [Abstract] [Full Text] [Related]

  • 34. Neuroleptic malignant syndrome and malignant hyperthermia.
    Wijeratne C.
    Aust N Z J Psychiatry; 1996 Dec 22; 30(6):874. PubMed ID: 9034482
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Electroconvulsive and dantrolene treatment of acute febrile catatonia. A case report].
    Renfordt E, Wardin B.
    Nervenarzt; 1985 Mar 22; 56(3):153-6. PubMed ID: 3990884
    [No Abstract] [Full Text] [Related]

  • 37. [Malignant neuroleptic syndrome. A review of epidemiology, risk factors, diagnosis, differential diagnosis and pathogenesis of MNS].
    Andreassen MD, Pedersen S.
    Ugeskr Laeger; 2000 Mar 06; 162(10):1366-70. PubMed ID: 10745673
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [The application of electroconvulsive therapy in neuroleptic malignant syndrome treatment in patient with catatonic schizophrenia].
    Kucia K, Warchala A.
    Wiad Lek; 2005 Mar 06; 58(9-10):572-4. PubMed ID: 16529073
    [Abstract] [Full Text] [Related]

  • 40. Successful treatment of a complicated case of neuroleptic malignant syndrome.
    Lappa A, Podestà M, Capelli O, Castagna A, Di Placido G, Alampi D, Semeraro F.
    Intensive Care Med; 2002 Jul 06; 28(7):976-7. PubMed ID: 12122539
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.